Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/11/2025

Indications for SMA Genetic Testing in Males

Primary Clinical Indications

  • Males presenting with progressive muscle weakness, hypotonia with preserved or diminished reflexes, or a family history of SMA, should undergo genetic testing for Spinal Muscular Atrophy (SMA) 1
  • Unexplained motor developmental delay or regression in males should prompt consideration of SMA testing, especially when muscle enzyme levels are normal or only mildly elevated 1
  • Males with unexplained muscle weakness and myopathic EMG findings should be tested for SMA, particularly when other muscular dystrophies have been excluded 1
  • Anterior horn cell disease patterns on EMG with progressive weakness indicate testing for SMA as a primary differential diagnosis 4

Differential Diagnosis Considerations

  • Males with progressive muscle weakness and normal or mildly elevated creatine kinase levels should be tested for SMA, unlike Duchenne muscular dystrophy which shows significantly elevated creatine kinase levels 5
  • Absence of dystrophin gene mutations in males with progressive weakness warrants SMA genetic testing as a next step 1, 5
  • Congenital myopathies typically show hypotonia with preserved reflexes, whereas SMA characteristically presents with diminished or absent reflexes 2, 3

REFERENCES

3

Duchenne Muscular Dystrophy Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4

Congenital Myopathy Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Congenital Myopathy Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025